Background illustration for clinical trials search

Paid Clinical Trials Utah

Discover 1,118 paid clinical trials in Utah. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

for
Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM,
Location: Boston MA, New Haven CT, Lake Success NY, The Bronx NY,
Sponsor: Black Diamond Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07326566

Phase 2, Recruiting
Active & Responsive

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

for
Lymphoma, Myeloma, Cytokine Release Syndrome,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 21+

Code: NCT07390071

Recruiting
Active & Responsive

A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)

for
Healthy Volunteers, Primary Sclerosing Cholangitis
Location: Salt Lake City UT
Sponsor: Takeda

Sex: All

Age: 18 - 68

Code: NCT07229911

Phase 1, Recruiting
Active & Responsive

PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)

for
Postoperative Pain, Acute
Location: Atlanta GA, Houston TX, Salt Lake City UT
Sponsor: Ensysce Biosciences

Sex: All

Age: 18 - 70+

Code: NCT06602271

Phase 3, Recruiting
Active & Responsive

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Lake Success NY, Wilmington DE, Washington D.C. DC,
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 2 - 17

Code: NCT07221851

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of JNT-517 in Participants With Phenylketonuria (PKU)

for
Phenylketonuria
Location: Pittsburgh PA, Tampa FL, Gainesville FL, Nashville TN,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 4+

Code: NCT06971731

Phase 3, Recruiting
Active & Responsive

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

for
Still´s Disease
Location: Salt Lake City UT, Portland OR
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 1+

Code: NCT07203001

Phase 2, Recruiting
Active & Responsive

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

for
Hypercholesterolaemia
Location: Sherbrooke, Millville NJ, Stouffville,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07619131

Phase 3, Recruiting
Active & Responsive

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: East Brunswick NJ, Fairfax VA, Grand Rapids MI,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT07145255

Phase 1, Phase 2, Recruiting
Active & Responsive

Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

for
Breast Cancer Female, Gynecologic Cancer
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Female

Age: 18+

Code: NCT07120100

Recruiting
Active & Responsive

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

for
Fabry Disease
Location: Fairfax VA, Atlanta GA, Cincinnati OH, Iowa City IA,
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All

Age: 2 - 17

Code: NCT06328608

Phase 2, Phase 3, Recruiting
Active & Responsive

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Baltimore MD, Richmond VA, Rochester NY, Gainesville FL,
Sponsor: Dyne Therapeutics

Sex: All

Age: 16+

Code: NCT07486934

Phase 3, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Hauppauge NY, Cherry Hill NJ, Bethlehem PA,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07440225

Phase 2, Phase 3, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase 1, Phase 2, Recruiting
Active & Responsive

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

for
Prostate Cancer, Metastatic Prostate Cancer,
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: Male

Age: 21+

Code: NCT07032584

Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Boston MA, North Haven CT, New York NY, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase 3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase 3, Recruiting
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: New York NY, Philadelphia PA, Washington D.C. DC,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase 2, Phase 3, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase 3, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Boston MA, Providence RI, Worcester MA, Hartford CT,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase 3, Recruiting

Popular cities in Utah

Offering a robust healthcare network and esteemed research institutions, Utah is a significant hub for clinical trials. Leading centers like the University of Utah Health, Huntsman Cancer Institute, and the Intermountain Healthcare system are at the forefront of medical research and innovation. Utah's strong emphasis on research and its collaborative environment make it a prominent state for conducting impactful clinical trials.

Why choose Utah for clinical trials?

Utah offers distinct advantages for those participating in clinical trials. The state's diverse population, combined with its strong emphasis on community health and wellness, enriches the research landscape with a wide range of participants. Utah is also recognized for its innovative research environment, with a notable focus on advancing medical science and exploring cutting-edge treatments, particularly in pediatrics.

Choosing to participate in a clinical trial in Utah means contributing to crucial medical research while benefiting from a supportive and well-established clinical research system. Utah’s commitment to excellence in research, along with its collaborative approach and advanced facilities, makes it an excellent choice for those looking to engage in meaningful and impactful studies.

Common conditions studied in Utah

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Utah